Table 3. Frequency of occurrence (%) of the findings of the histopathological evaluation of the different groups before and after the application of MSCs on D0 (before) and D82 (after).
Mild group | PI | Epidermal hyperplasia | SDE | |||
---|---|---|---|---|---|---|
D0 | D82 | D0 | D82 | D0 | D82 | |
Negative (−) | 14.29 | 28.57 | 28.57 | 28.57 | 28.57 | 42.86 |
Mild (+) | 71.42 | 57.14 | 42.86 | 71.43 | 42.86 | 57.14 |
Moderate (++) | 14.29 | 14.29 | – | – | 28.57 | – |
Severe (+++) | – | – | 28.57 | – | – | – |
Moderate group | PI | Epidermal hyperplasia | SDE | |||
D0 | D82 | D0 | D82 | D0 | D82 | |
Negative (-) | 14.29 | 28.57 | 28.57 | 28.57 | 28.57 | 42.86 |
Mild (+) | 71.42 | 57.14 | 42.86 | 71.43 | 42.86 | 57.14 |
Moderate (++) | 14.29 | 14.29 | – | – | 28.57 | – |
Severe (+++) | – | – | 28.57 | – | – | – |
Severe group | PI | Epidermal hyperplasia | SDE | |||
D0 | D82 | D0 | D82 | D0 | D82 | |
Negative (-) | – | – | – | 16.67 | – | – |
Mild (+) | 33.34 | – | 16.67 | 16.67 | 50 | 66.67 |
Moderate (++) | 33.33 | 66.67 | 50 | 50 | 33.33 | 33.33 |
Severe (+++) | 33.33 | 33.33 | 33.33 | 16.66 | 16.67 | – |